The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses in patients with a variety of cancers. This can be achieved by antibodies blocking the cytotoxic T lymphocyte-associated pro...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!